Lean people with HIV can still develop fatty liver disease
GLP-1 agonists could be a global game-changer, but need to be accessible and affordable
People with HIV fare as well as those without it after liver transplants
HIV status does not affect liver transplant outcomes, 15-year Spanish study finds
Most liver disease in people with HIV in low and middle-income countries is caused by metabolic disorders
Top 5 stories on co-morbidities affecting people with HIV from CROI 2024
Semaglutide improves fatty liver disease and inflammation in people with HIV
Heavy drinking, metabolic disorders and hepatotoxic antiretrovirals are risk factors for chronic liver disease in UK cohort
Fatty liver disease raises the risk of cardiovascular disease in people with HIV
